Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00418093
Status:
TERMINATED
Last Update Posted:
2014-06-19
First Post:
2007-01-02
Brief Title:
Oxaliplatin Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cancer |
| Ovarian Cancer |
| Fallopian Tube Cancer |
Keywords:
| Name | View |
|---|---|
| mullerian carcinoma | View |